User
Our local employees are always happy to answer your questions. Highly trained and experienced teams in your country can provide quick, helpful, and comprehensive support.
Miltenyi Biotec Inc.
2303 Lindbergh Street
Auburn, CA 95602
USA
Phone: +1 800 FOR MACS
+1 530 888 8871
Fax: +1 530 888 8925
E-Mail: macs@miltenyibiotec.com
Web: www.miltenyibiotec.com
For immediate technical support, use our live chat. Connect with us
Orders
Phone: +1 866 811 4466
Fax: +1 877 591 1060
E-Mail: orderdesk@miltenyibiotec.com
Technical support - Research products
Phone: +1 800 FOR MACS
Fax: +1 530 745 2806
E-Mail: science@miltenyibiotec.com
Technical support - Clinical products
Phone: +1 800 FOR MACS
Fax: +1 530 745 2806
E-Mail: science@miltenyibiotec.com
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
Immunosuppression in the human tumor microenvironment
Friday, February 1, 2019
09:00 a.m.–06:00 p.m.
Salle des Guichets
Bip, Rue Royale 2–4
Brussels, Belgium
| 09:00 a.m. | Opening: Have we yet understood the key mechanisms to unleash the anti-tumor response? |
| Tumor microenvironment: The innate immune system | |
| 09:30 a.m. | Human tumor-associated macrophage transcriptional landscape in solid tumors |
| 10:05 a.m. | NK cell activation and exhaustion: two sides of the same coin Thierry Walzer, Lyon, France |
| 10:40 a.m. | Coffee break |
| 11:20 a.m. | The diversity of cancer-related neutrophils. Their impact on the tumor microenvironment and cancer progression. Zvi Fridlander, Jerusalem, Israel |
| Tumor microenvironment: T lymphocytes | |
| 11:55 a.m. | Targeting GARP on Tregs: a novel approach for the immunotherapy of cancer Sophie Lucas, Brussels, Belgium |
| 12:30 p.m. | Deciphering the immune landscape of the human cancer microenvironment Massimiliano Pagani, Milan, Italy |
| 01:05 p.m. | Lunch break |
| Metabolism and glycosylation | |
| 02:30 p.m. | Metabolic interventions to enhance anti-tumor immune responses Roger Geiger, Bellinzona, Switzerland |
| 03:05 p.m. | Glycans as immune checkpoints for cancer immunotherapy Yvette van Kooyk, Amsterdam, Netherlands |
| 03:40 p.m. | Coffee break |
| Dendritic cell and CAR T cell therapies | |
| 04:00 p.m. | Development of 21st century cancer vaccines Carl Figdor, Nijmegen, Netherlands |
| 04:35 p.m. | Dissecting mechanisms of tumor immune surveillance and immunotherapies at the single cell level Philippe Bousso, Paris, France |
| 05:10 p.m. | Moving CAR T cell therapy into solid tumors Gianpietro Dotti, Chapel Hill, North Carolina, USA |
| 05:45 p.m. | Closing/Farewell Tim Oliver Stolle (Miltenyi Biotec), Leiden, Netherlands |
| 06:00 p.m. | Celebration party |
Play video